Log In
BCIQ
Print this Print this
 

ScoliScore AIS Prognostic Test

  Manage Alerts
Collapse Summary General Information
Company Transgenomic Inc.
DescriptionPrognostic genetic test for scoliosis
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationMusculoskeletal, Diagnostic
Indication DetailsPredict the progression and severity of scoliosis
Regulatory Designation
PartnerJohnson & Johnson

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$4.4M

$4.4M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/03/2012

$4.4M

$4.4M

0

Get a free BioCentury trial today